Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

News

Microdose Provider Pricing Changes

Released: · Last reviewed:

Latest — November 8, 2026

Each item is dated, sourced and marked confirmed or reported.

NexLife microdose plans now cost the same as its standard plans

Re-read on nexlife.us on November 8, 2026, the microdose tirzepatide page prints "$129 all-inclusive" with $125 / $119 / $115 a month on 3 / 6 / 12-month plans, and the microdose semaglutide page "$109 all-inclusive" with $105 / $99 / $95. On October 15 the tirzepatide page showed $189 / $159 / $150 / $147 and the semaglutide page conflicting ladders.

What it means: For cash-pay patients: at NexLife a microdose no longer costs more than a standard plan; the dose your prescriber sets does not change the bill.

Source: nexlife.us microdose program pages · confirmed

Microdose plan prices re-read: Noom Med down to $179, program fees counted

We read seven programs that sell a named microdose plan. Noom Med now charges $179 a month after a $79 first 4-week supply (billed quarterly; $199 in July). Ivím Health prints a $74.99 monthly program fee beside its $133 tirzepatide and $75 semaglutide microdose prices. Lemonaid Health ($199 + $49 membership), AgelessRx, Good Girl Rx and PlexusDx enter our index; Henry Meds prints no microdose price.

What it means: All-in prices run $69 to $248 a month for both drugs; medians $149 (tirzepatide) and $99 (semaglutide).

Source: each program's own page; full report · confirmed

NexLife cuts standard compounded prices

NexLife's standard plans moved to $129 a month month to month for compounded tirzepatide ($125 / $119 / $115 on 3 / 6 / 12 months; $1,380 a year) and $109 for compounded semaglutide ($105 / $99 / $95; $1,140), from $169 and $139.

What it means: Eden Health's $129 tirzepatide (no membership, read October 15) now equals NexLife's month-to-month price; several programs still print lower figures.

Source: nexlife.us plan pages · confirmed

Earlier — September 4, 2026

Price moves recorded that month (historical):

NexLife September 2026 card: tirzepatide $215 → $169 month-to-month, semaglutide $165 → $139

Re-read on NexLife's live plans pages: standard tirzepatide now $169 / $159 / $149 / $139 per month across monthly / 3 / 6 / 12-month terms (from $215 / $195 / $190 / $186) and standard semaglutide $139 / $132 / $125 / $119 (from $165 / $149 / $147 / $145). A microdose tirzepatide card announced on August 31 had not reached the program page on September 4, which still showed $189 → $147. Microdose semaglutide and ODT cards unchanged. Full note: NexLife September 2026 price update.

Yucca Health's tirzepatide plan table read first-party

Yucca Health's tirzepatide page published $258 a month month to month and $225 a month on six months (read September 4, 2026).

Wegovy pill 4 mg offer ends August 31

NovoCare's published pricing keeps the 1.5 mg oral dose at $149/month but steps the 4 mg dose from $149 to $199 after August 31, 2026 — the entry price of the approved-pill lane shifts in three weeks.

Wegovy HD (7.2 mg) cash price: $399/month

The higher-dose semaglutide approved March 19 (≈20.7% average weight loss in STEP UP) sells through NovoCare at $399/month — $50 over standard pens; the $199 two-fill intro continues through December 31.

Monitored category — items publish only when newsworthy and sourced.

The provider-pricing category records verified price changes: old price, new price, effective date, plan, fee, and dose category, each tied to a first-party source capture. Changes flow from and into the provider pricing dataset so the history stays consistent.

Category page indexable; items gated. An item appears here only with a primary source and an event date. We would rather show nothing than manufacture freshness.

What we watch in this category

Primary sources monitored

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.